drugset
drugset / Trial / NCT03246581

Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers

NCT03246581 ↗

Phase 1 Completed 40 enrolled Kindeva Drug Delivery 3M · collabSimbec Research · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the absorption of a test inhalation product with the reference product in healthy volunteers.

Timeline

Start
2017-07-13
Primary completion
2018-01-21
Completion
2018-05-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified — Inhaled

Indications

No indication recorded.